Troubled by the new coronavirus strain and rapid increase in caseload, the UK on Wednesday approved the Oxford University-AstraZeneca COVID-19 vaccine for use after authorisation by the country's medicines regulator. The UK has already vaccinated hundreds of thousands of patients with the Pfizer/BioNTech vaccine and its rollout will continue. The National Health Service (NHS) in the UK will begin putting their extensive preparations into action to roll out the Oxford University/AstraZeneca vaccine, the government said. "Everyone will still receive their second dose and this will be within 12 weeks of their first. The second dose completes the course and is important for longer term protection," the government said.

Source: dna December 30, 2020 09:33 UTC